Replies to post #18376 on Aytu BioScience Inc. (AYTU)

[Drugdoctor]

Well, the Almost Human division of this company they bought, is a division that reports very nice sales... However for every $1.00 of revenue, it usually costs them $1.10 in expenses :-(

So if the 11 million dollar sales projections that are being thrown out for the 4th quarter are accurate, with net losses again, it will be very disappointing to many investors, as we believed the COV19 tests they were selling would make them profitable...

Still on the sidelines... Good luck...

[ShawnP123]

That's the same remark people said about INNV.